Literature DB >> 2559316

New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.

V Aleixandre1, A Urios, G Herrera, M Blanco.   

Abstract

We isolated new gyrA and gyrB mutations in Escherichia coli which have a graded effect on DNA supercoiling. The mutants, selected respectively for resistance to nalidixic acid and coumermycin, were sorted by means of a rapid in vivo assay of DNA gyrase activity (Aleixandre and Blanco 1987). Cells carrying a gyrB (Cour) mutation usually showed a decrease in DNA supercoiling, which would indicate a reduction in gyrase activity. In contrast, most of the gyrA (Nalr) mutations had no significant effect on DNA supercoiling. Moreover, they conferred a high level of resistance to nalidixic acid and other quinolones, thus being similar to the gyrA (Nalr) mutants currently used. We also detected rare gyrA mutants showing a reduction in DNA gyrase activity. These mutants were, in addition, resistant to only low concentrations of quinolones, which allowed us to use the phenotype of partial quinolone resistance as an indicator to score gyrA mutations affecting DNA supercoiling. When gyrB mutations were introduced into the gyrA mutants, these became more sensitive to quinolones and a decrease in supercoiling was observed. Moreover, the topA10 mutation sensitized gyrA (Nalr) cells to quinolones. We conclude therefore that the GyrA-dependent quinolone resistance is diminished as a consequence of the reduction either in topoisomerase I or gyrase activities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559316     DOI: 10.1007/BF00261192

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  22 in total

1.  Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.

Authors:  L L Shen; L A Mitscher; P N Sharma; T J O'Donnell; D W Chu; C S Cooper; T Rosen; A G Pernet
Journal:  Biochemistry       Date:  1989-05-02       Impact factor: 3.162

Review 2.  Inhibitors of DNA topoisomerases.

Authors:  K Drlica; R J Franco
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

Review 3.  Biology of bacterial deoxyribonucleic acid topoisomerases.

Authors:  K Drlica
Journal:  Microbiol Rev       Date:  1984-12

4.  Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors:  L L Shen; A G Pernet
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.

Authors:  G J Pruss; R J Franco; S G Chevalier; S H Manes; K Drlica
Journal:  J Bacteriol       Date:  1986-10       Impact factor: 3.490

6.  DNA supercoiling in gyrase mutants.

Authors:  T R Steck; G J Pruss; S H Manes; L Burg; K Drlica
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

7.  Lambda transducing phages for the nalA gene of Escherichia coli and conditional lethal nalA mutations.

Authors:  K N Kreuzer; K McEntee; A P Geballe; N R Cozzarelli
Journal:  Mol Gen Genet       Date:  1978-11-29

8.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Quinolone-resistant mutations of the gyrA gene of Escherichia coli.

Authors:  H Yoshida; T Kojima; J Yamagishi; S Nakamura
Journal:  Mol Gen Genet       Date:  1988-01

10.  Mutations in the gene coding for Escherichia coli DNA topoisomerase I affect transcription and transposition.

Authors:  R Sternglanz; S DiNardo; K A Voelkel; Y Nishimura; Y Hirota; K Becherer; L Zumstein; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  8 in total

1.  Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

Authors:  S Bagel; V Hüllen; B Wiedemann; P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.

Authors:  V Aleixandre; G Herrera; A Urios; M Blanco
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.

Authors:  P Heisig; R Tschorny
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 4.  Mode of action of the new quinolones: new data.

Authors:  D C Hooper; J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 5.  Functions of the gene products of Escherichia coli.

Authors:  M Riley
Journal:  Microbiol Rev       Date:  1993-12

Review 6.  Mechanisms of quinolone resistance.

Authors:  B Wiedemann; P Heisig
Journal:  Infection       Date:  1994       Impact factor: 3.553

7.  Differential gene expression by RamA in ciprofloxacin-resistant Salmonella Typhimurium.

Authors:  Jie Zheng; Fei Tian; Shenghui Cui; Jiuzhou Song; Shaohua Zhao; Eric W Brown; Jianghong Meng
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

8.  The MukB-topoisomerase IV interaction mutually suppresses their catalytic activities.

Authors:  Rupesh Kumar; Soon Bahng; Kenneth J Marians
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.